(Q42518375)

English

Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome (English)

1 reference

Europe PubMed Central

1 November 2017

0 references

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Dorte Glintborg

1

1 reference

Europe PubMed Central

1 November 2017

Jan Erik Henriksen

5

1 reference

Europe PubMed Central

1 November 2017

3

object named as

Kurt Højlund

1 reference

Europe PubMed Central

1 November 2017

Allan Flyvbjerg

8

object named as

Allan Flyvbjerg

1 reference

Europe PubMed Central

1 November 2017

Marianne Andersen

object named as

Marianne Andersen

9

0 references

Anne Pernille Hermann

6

object named as

Anne Pernille Hermann

1 reference

Europe PubMed Central

1 November 2017

2

object named as

Jan Frystyk

1 reference

Europe PubMed Central

1 November 2017

author name string

Kristian Kjaer Andersen

4

1 reference

Europe PubMed Central

1 November 2017

Claus Hagen

7

1 reference

Europe PubMed Central

1 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 September 2007

1 reference

Europe PubMed Central

1 November 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

1 November 2017

68

1 reference

Europe PubMed Central

1 November 2017

2

1 reference

Europe PubMed Central

1 November 2017

165-174

1 reference

Europe PubMed Central

1 November 2017

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Regulation of adipocytokines and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

The role of the novel adipocyte-derived hormone adiponectin in human disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Evidence for altered adipocyte function in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Determinants of circulating adiponectin in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Adiponectin--a key adipokine in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Clinical practice. Hirsutism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

The theoretical bases of indirect calorimetry: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Selective insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03015.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2007.03015.X

1 reference

Europe PubMed Central

1 November 2017

release_6z7vfkl4bvfnfpjlyihjznivb4

1 reference

https://api.fatcat.wiki/v0/release/6z7vfkl4bvfnfpjlyihjznivb4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42518375&oldid=1960472017"